English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
冠科美博在中國完成復發或難治性急性髓細胞白血病uproleselan藥物的三期臨床橋接研究入組
Jan 03, 2024 20:09 HKT
ChemPartner Unveils Highly Anticipated Biology Database
Dec 23, 2023 07:00 HKT
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Dec 22, 2023 09:00 HKT
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作
Dec 22, 2023 09:00 HKT
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作
Dec 22, 2023 09:00 HKT
欧康维视生物: OT-703获批于香港上市,为糖尿病性黄斑水肿患者治疗带来新选择
Dec 20, 2023 20:53 HKT
歐康維視生物: OT-703獲批於香港上市,為糖尿病性黃斑水腫患者治療帶來新選擇
Dec 20, 2023 20:52 HKT
Ocumension Therapeutics: The Approval Received For Marketing OT-703 In Hong Kong, A New Option For Patients With Diabetic Macular Edema
Dec 20, 2023 20:51 HKT
TANAKA Precious Metals beteiligt sich an "Global Vascular", einem medizinischen Venture-Unternehmen, das Stent-Abwurfsysteme für die Behandlung von Arteriosklerose in den unteren Extremitäten entwickelt
Dec 19, 2023 18:00 HKT
田中贵金属工业对开发下肢动脉硬化症用支架输送系统的医疗器械风险企业“Global Vascular”进行出资
Dec 19, 2023 11:00 HKT
田中貴金屬工業對開發下肢動脈硬化症用支架輸送系統的醫療儀器風險企業「Global Vascular」進行出資
Dec 19, 2023 11:00 HKT
다나까귀금속공업, 하지동맥 경화증용 스텐트 전달 시스템을 개발하는 의료기기 벤처기업 'Global Vascular'에 출자
Dec 19, 2023 10:00 HKT
Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China
Dec 12, 2023 22:20 HKT
康沣生物心脏冷冻消融系统获NMPA批准上市
Dec 12, 2023 10:53 HKT
康灃生物心臟冷凍消融系統獲NMPA批准上市
Dec 12, 2023 10:52 HKT
Cryofocus Medtech Obtains NMPA Approval for the AF Cryoablation System
Dec 12, 2023 10:50 HKT
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
Dec 11, 2023 20:00 HKT
Moderna公司回顧了在第二次環境、社會和治理(ESG)投資者活動中取得的進展和雄心
Dec 11, 2023 20:00 HKT
As Health Systems Struggle With Nursing Shortages, CGFNS International Sees a Sharp Rise in Nurses Seeking to Migrate to the U.S.
Dec 06, 2023 22:00 HKT
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 05, 2023 10:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: